tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Kaveri Pohlman - 3 which are a Buy (100%)
Analyst Kaveri Pohlman works at BTIG and is covering the Healthcare sector with 6 price targets and ratings displayed on 4 stocks.
Kaveri Pohlman's average stock forecast success ratio is 25% with an average time for price targets to be met of 59.5 days.
Most recent stock forecast was given on MGNX, MacroGenics at 21-Mar-2023.
Analyst best performing recommendations are on MGNX (MACROGENICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 7/11/2022. The price target of $6 was fulfilled within 119 days with a profit of $2.45 (69.01%) receiving and performance score of 5.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
3.19
$1.83 (134.56%)
3.2
1 months 12 days ago
1/5 (20%)
$4.1 (152.00%)
56
Hold
2
$0.64 (47.06%)
16
5 months 24 days ago
0/4 (0%)
$7.25 (47.56%)
Sell
14
10 months 11 days ago
0/1 (0%)
$6.41 (84.45%)
Hold
16
1 years 1 months 16 days ago
0/3 (0%)
$10.39 (174.95%)
Buy
2
$0.64 (47.06%)
10
1 years 2 months 14 days ago
3/6 (50%)
$5.36 (70.73%)
119
What Year was the first public recommendation made by Kaveri Pohlman?
